Literature DB >> 14747375

Exogenous PDGF-D is a potent mesangial cell mitogen and causes a severe mesangial proliferative glomerulopathy.

Kelly L Hudkins1, Debra G Gilbertson, Matthew Carling, Sekiko Taneda, Steven D Hughes, Matthew S Holdren, Thomas E Palmer, Stavros Topouzis, Aaron C Haran, Andrew L Feldhaus, Charles E Alpers.   

Abstract

The PDGF family consists of at least four members, PDGF-A, -B, -C, and -D. All of the PDGF isoforms bind and signal through two known receptors, PDGF receptor-alpha and PDGF receptor-beta, which are constitutively expressed in the kidney and are upregulated in specific diseases. It is well established that PDGF-B plays a pivotal role in the mediation of glomerular mesangial cell proliferation. However, little is known of the roles of the recently discovered PDGF-C and -D in mediating renal injury. In this study, adenovirus constructs encoding PDGF-B, -C, and -D were injected into mice. Mice with high circulating levels of PDGF-D developed a severe mesangial proliferative glomerulopathy, characterized by enlarged glomeruli and a striking increase in glomerular cellularity. The PDGF-B-overexpressing mice had a milder proliferative glomerulopathy, whereas the mice overexpressing PDGF-C and those that received adenovirus alone showed no measurable response. Mitogenicity of PDGF-D and -B for mesangial cells was confirmed in vitro. These findings emphasize the importance of engagement of PDGF receptor-beta in transducing mesangial cell proliferation and demonstrate that PDGF-D is a major mediator of mesangial cell proliferation. Finally, this approach has resulted in a unique and potentially valuable model of mesangial proliferative glomerulopathy and its resolution.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747375     DOI: 10.1097/01.asn.0000108522.79652.63

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  15 in total

Review 1.  Signal transduction in podocytes--spotlight on receptor tyrosine kinases.

Authors:  Jochen Reiser; Sanja Sever; Christian Faul
Journal:  Nat Rev Nephrol       Date:  2014-01-07       Impact factor: 28.314

2.  PDGF-C mediates glomerular capillary repair.

Authors:  Peter Boor; Claudia R C van Roeyen; Uta Kunter; Luigi Villa; Eva Bücher; Bernd Hohenstein; Christian P M Hugo; Ulf Eriksson; Simon C Satchell; Peter W Mathieson; Frank Eitner; Jürgen Floege; Tammo Ostendorf
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

Review 3.  Targeting CTGF, EGF and PDGF pathways to prevent progression of kidney disease.

Authors:  Helena M Kok; Lucas L Falke; Roel Goldschmeding; Tri Q Nguyen
Journal:  Nat Rev Nephrol       Date:  2014-10-14       Impact factor: 28.314

4.  Selective stimulation of VEGFR2 accelerates progressive renal disease.

Authors:  Waichi Sato; Katsuyuki Tanabe; Tomoki Kosugi; Kelly Hudkins; Miguel A Lanaspa; Li Zhang; Martha Campbell-Thompson; Qiuhong Li; David A Long; Charles E Alpers; Takahiko Nakagawa
Journal:  Am J Pathol       Date:  2011-05-05       Impact factor: 4.307

Review 5.  [New approaches in progressive kidney diseases].

Authors:  P Boor
Journal:  Pathologe       Date:  2012-11       Impact factor: 1.011

Review 6.  Imatinib mesylate use in refractory eosinophilic granulomatosis with polyangiitis: a literature review and a case report.

Authors:  Tatiana V Beketova; Mikhail Y Volkov; Evgeniy A Naryshkin; Tatiana M Novoselova; Evgeniy L Nasonov
Journal:  Clin Rheumatol       Date:  2018-03-21       Impact factor: 2.980

7.  Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors.

Authors:  Xuri Li; Marc Tjwa; Lieve Moons; Pierre Fons; Agnes Noel; Annelii Ny; Jian Min Zhou; Johan Lennartsson; Hong Li; Aernout Luttun; Annica Pontén; Laetitia Devy; Ann Bouché; Hideyasu Oh; Ann Manderveld; Silvia Blacher; David Communi; Pierre Savi; Françoise Bono; Mieke Dewerchin; Jean-Michel Foidart; Monica Autiero; Jean-Marc Herbert; D Collen; Carl-Henrik Heldin; Ulf Eriksson; Peter Carmeliet
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

Review 8.  Targeting the progression of chronic kidney disease.

Authors:  Marta Ruiz-Ortega; Sandra Rayego-Mateos; Santiago Lamas; Alberto Ortiz; Raul R Rodrigues-Diez
Journal:  Nat Rev Nephrol       Date:  2020-02-14       Impact factor: 28.314

9.  Integral role of platelet-derived growth factor in mediating transforming growth factor-β1-dependent mesenchymal stem cell stiffening.

Authors:  Deepraj Ghosh; Loukia Lili; Daniel J McGrail; Lilya V Matyunina; John F McDonald; Michelle R Dawson
Journal:  Stem Cells Dev       Date:  2013-11-08       Impact factor: 3.272

10.  Tissue-type plasminogen activator is not necessary for platelet-derived growth factor-c activation.

Authors:  Kimberly J Riehle; Melissa M Johnson; Fredrik Johansson; Renay L Bauer; Brian J Hayes; Debra G Gilbertson; Aaron C Haran; Nelson Fausto; Jean S Campbell
Journal:  Biochim Biophys Acta       Date:  2013-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.